Lawsuit Says St. Jude Stuck Insurer With Faulty Pacemaker Costs
Executive Summary
A court case claims that St. Jude Medical’s handling of implant battery issues several years ago defrauded insurers.
You may also be interested in...
Final Countdown To St. Jude Acquisition – Abbott Scores US Antitrust Approval
Abbott has scored US FTC antitrust approval for its proposed $25bn acquisition of St. Jude. The approval comes with two conditions: that Abbott divests the vascular closure device and steerable sheath businesses to Terumo, and that it notifies the FTC if it intends to acquire lesion-assessing ablation catheter assets from Advanced Cardiac Therapeutics.
St. Jude Warns Of Battery-Depletion Issues With Some ICDs
St. Jude Medical has issued a warning about premature battery depletion issues in some ICDs, but says it has already fixed the problem. Analysts say it is not likely to have any impact on Abbott’s plans to acquire St. Jude by the end of 2016.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.